Remedy with de-escalated actinium (Ac)-225–prostate-specific membrane antigen (PSMA)-617 or a mix of lutetium (Lu)-177/Ac-225–PSMA-617 resulted in comparable median total survival and...
MELBOURNE, Australia, July 29, 2024 (GLOBE NEWSWIRE) -- Telix Prescribed drugs Restricted (ASX: TLX, Telix, the Firm) as we speak publicizes the opening...